Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001326110-25-000093
Filing Date
2025-06-20
Accepted
2025-06-20 18:34:47
Documents
1
Period of Report
2025-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1750458881.html 4  
1 FORM 4 wk-form4_1750458881.xml 4 4051
  Complete submission text file 0001326110-25-000093.txt   5775
Mailing Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121
Business Address 3530 JOHN HOPKINS COURT SAN DIEGO CA 92121 (844) 696-5235
ImmunityBio, Inc. (Issuer) CIK: 0001326110 (see all company filings)

EIN.: 431979754 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O CELLDEX THERAPEUTICS, INC 53 FRONTAGE ROAD, SUITE 220 HAMPTON NJ 08827
Business Address
Cohen Cheryl (Reporting) CIK: 0001529371 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37507 | Film No.: 251062625